Dynavax Long Term Debt vs Deferred Long Term Liab Analysis

DVAX Stock

USD 12.82 0.13 1.02%

Dynavax Technologies financial indicator trend analysis is much more than just examining Dynavax Technologies latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dynavax Technologies is a good investment. Please check the relationship between Dynavax Technologies Long Term Debt and its Deferred Long Term Liab accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.

Long Term Debt vs Deferred Long Term Liab

Long Term Debt vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Dynavax Technologies Long Term Debt account and Deferred Long Term Liab. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Dynavax Technologies' Long Term Debt and Deferred Long Term Liab is 0.96. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Dynavax Technologies, assuming nothing else is changed. The correlation between historical values of Dynavax Technologies' Long Term Debt and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Dynavax Technologies are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Long Term Debt i.e., Dynavax Technologies' Long Term Debt and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

0.96

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Long Term Debt

Long-term debt is a debt that Dynavax Technologies has held for over one year. Long-term debt appears on Dynavax Technologies balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Dynavax Technologies balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Dynavax Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dynavax Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.At this time, Dynavax Technologies' Selling General Administrative is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 186.37 in 2025, whereas Tax Provision is likely to drop slightly above 945.2 K in 2025.

	2024	2025 (projected)
Interest Income	30.8M	32.3M
Non Recurring	15.4M	16.1M

Interest Income Non Recurring

Dynavax Technologies fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Other Assets	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Other Current Liab	Total Current Liabilities	Accounts Payable	Cash	Short Term Investments	Other Current Assets	Common Stock	Property Plant Equipment	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Non Current Liabilities Total	Property Plant And Equipment Gross	Total Current Assets	Net Receivables
Total Assets		0.89	-0.44	-0.2	0.95	0.85	0.86	0.67	0.52	0.23	0.82	0.86	0.54	0.24	0.89	0.93	0.55	0.24	0.8	0.66	0.98	0.23	0.91	0.91	0.98	0.79
Total Stockholder Equity	0.89		-0.19	-0.21	0.8	0.75	0.55	0.34	0.13	0.17	0.53	0.97	0.18	0.26	0.63	0.78	0.19	0.31	0.49	0.33	0.96	0.25	0.75	0.82	0.95	0.57
Retained Earnings	-0.44	-0.19		0.48	-0.67	-0.78	-0.61	-0.53	-0.45	-0.65	-0.45	-0.23	-0.42	0.01	-0.73	-0.64	-0.39	-0.35	-0.57	-0.49	-0.34	0.01	-0.54	-0.56	-0.36	-0.41
Other Assets	-0.2	-0.21	0.48		-0.24	-0.44	-0.14	-0.17	-0.18	-0.26	-0.21	-0.17	-0.16	-0.41	-0.28	-0.21	-0.16	0.07	-0.19	-0.16	-0.2	-0.41	-0.01	-0.17	-0.19	-0.14
Common Stock Shares Outstanding	0.95	0.8	-0.67	-0.24		0.94	0.87	0.68	0.49	0.39	0.75	0.79	0.52	0.14	0.93	0.98	0.49	0.41	0.81	0.67	0.9	0.13	0.93	0.93	0.9	0.78
Other Stockholder Equity	0.85	0.75	-0.78	-0.44	0.94		0.75	0.53	0.37	0.55	0.62	0.77	0.37	0.13	0.88	0.92	0.36	0.46	0.66	0.5	0.83	0.13	0.84	0.9	0.84	0.59
Total Liab	0.86	0.55	-0.61	-0.14	0.87	0.75		0.86	0.82	0.24	0.93	0.51	0.81	0.15	0.96	0.87	0.82	0.1	0.95	0.87	0.75	0.15	0.85	0.78	0.76	0.84
Other Current Liab	0.67	0.34	-0.53	-0.17	0.68	0.53	0.86		0.91	0.12	0.92	0.22	0.92	0.1	0.8	0.63	0.86	-0.22	0.96	0.99	0.52	0.1	0.55	0.46	0.5	0.93
Total Current Liabilities	0.52	0.13	-0.45	-0.18	0.49	0.37	0.82	0.91		-0.04	0.9	0.02	0.98	0.13	0.72	0.48	0.98	-0.42	0.88	0.93	0.35	0.13	0.4	0.31	0.34	0.76
Accounts Payable	0.23	0.17	-0.65	-0.26	0.39	0.55	0.24	0.12	-0.04		0.04	0.28	-0.14	-0.02	0.41	0.35	-0.08	0.57	0.11	0.04	0.23	-0.02	0.41	0.48	0.25	0.01
Cash	0.82	0.53	-0.45	-0.21	0.75	0.62	0.93	0.92	0.9	0.04		0.42	0.9	0.15	0.87	0.72	0.91	-0.24	0.95	0.92	0.71	0.15	0.66	0.6	0.7	0.88
Short Term Investments	0.86	0.97	-0.23	-0.17	0.79	0.77	0.51	0.22	0.02	0.28	0.42		0.05	0.25	0.61	0.79	0.08	0.49	0.39	0.2	0.94	0.24	0.79	0.87	0.94	0.44
Other Current Assets	0.54	0.18	-0.42	-0.16	0.52	0.37	0.81	0.92	0.98	-0.14	0.9	0.05		0.13	0.7	0.5	0.97	-0.43	0.91	0.95	0.38	0.13	0.4	0.3	0.36	0.82
Common Stock	0.24	0.26	0.01	-0.41	0.14	0.13	0.15	0.1	0.13	-0.02	0.15	0.25	0.13		0.14	0.17	0.16	0.04	0.17	0.16	0.24	1.0	0.08	0.15	0.24	0.2
Property Plant Equipment	0.89	0.63	-0.73	-0.28	0.93	0.88	0.96	0.8	0.72	0.41	0.87	0.61	0.7	0.14		0.93	0.72	0.21	0.9	0.79	0.8	0.13	0.88	0.87	0.81	0.78
Property Plant And Equipment Net	0.93	0.78	-0.64	-0.21	0.98	0.92	0.87	0.63	0.48	0.35	0.72	0.79	0.5	0.17	0.93		0.49	0.45	0.79	0.63	0.89	0.17	0.95	0.95	0.9	0.74
Current Deferred Revenue	0.55	0.19	-0.39	-0.16	0.49	0.36	0.82	0.86	0.98	-0.08	0.91	0.08	0.97	0.16	0.72	0.49		-0.43	0.85	0.9	0.41	0.16	0.42	0.34	0.4	0.72
Net Debt	0.24	0.31	-0.35	0.07	0.41	0.46	0.1	-0.22	-0.42	0.57	-0.24	0.49	-0.43	0.04	0.21	0.45	-0.43		-0.07	-0.24	0.29	0.04	0.54	0.57	0.33	-0.08
Non Current Assets Total	0.8	0.49	-0.57	-0.19	0.81	0.66	0.95	0.96	0.88	0.11	0.95	0.39	0.91	0.17	0.9	0.79	0.85	-0.07		0.97	0.66	0.17	0.71	0.63	0.66	0.95
Non Currrent Assets Other	0.66	0.33	-0.49	-0.16	0.67	0.5	0.87	0.99	0.93	0.04	0.92	0.2	0.95	0.16	0.79	0.63	0.9	-0.24	0.97		0.5	0.16	0.54	0.45	0.49	0.93
Cash And Short Term Investments	0.98	0.96	-0.34	-0.2	0.9	0.83	0.75	0.52	0.35	0.23	0.71	0.94	0.38	0.24	0.8	0.89	0.41	0.29	0.66	0.5		0.24	0.87	0.91	1.0	0.68
Common Stock Total Equity	0.23	0.25	0.01	-0.41	0.13	0.13	0.15	0.1	0.13	-0.02	0.15	0.24	0.13	1.0	0.13	0.17	0.16	0.04	0.17	0.16	0.24		0.08	0.15	0.23	0.2
Non Current Liabilities Total	0.91	0.75	-0.54	-0.01	0.93	0.84	0.85	0.55	0.4	0.41	0.66	0.79	0.4	0.08	0.88	0.95	0.42	0.54	0.71	0.54	0.87	0.08		0.97	0.89	0.65
Property Plant And Equipment Gross	0.91	0.82	-0.56	-0.17	0.93	0.9	0.78	0.46	0.31	0.48	0.6	0.87	0.3	0.15	0.87	0.95	0.34	0.57	0.63	0.45	0.91	0.15	0.97		0.92	0.57
Total Current Assets	0.98	0.95	-0.36	-0.19	0.9	0.84	0.76	0.5	0.34	0.25	0.7	0.94	0.36	0.24	0.81	0.9	0.4	0.33	0.66	0.49	1.0	0.23	0.89	0.92		0.66
Net Receivables	0.79	0.57	-0.41	-0.14	0.78	0.59	0.84	0.93	0.76	0.01	0.88	0.44	0.82	0.2	0.78	0.74	0.72	-0.08	0.95	0.93	0.68	0.2	0.65	0.57	0.66

Click cells to compare fundamentals

Dynavax Technologies Account Relationship Matchups

Dynavax Technologies fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	353.3M	1.0B	985.9M	997.1M	1.1B	1.2B
Total Stockholder Equity	58.7M	222.4M	581.0M	622.1M	715.4M	751.2M
Retained Earnings	(1.3B)	(1.2B)	(924.2M)	(930.6M)	(837.5M)	(879.4M)
Other Assets	3.6M	3.8M	368.9K	3.5M	3.2M	3.0M
Common Stock Shares Outstanding	100.8M	133.0M	150.8M	128.7M	148.0M	155.4M
Liabilities And Stockholders Equity	353.3M	1.0B	985.9M	997.1M	1.1B	1.2B
Other Stockholder Equity	1.4B	1.4B	1.5B	1.6B	1.8B	1.9B
Total Liab	294.6M	816.9M	404.8M	375.0M	431.3M	452.8M
Other Current Liab	32.6M	201.4M	143.2M	52.5M	60.3M	30.8M
Total Current Liabilities	77.4M	556.4M	150.1M	62.2M	71.5M	58.2M
Accounts Payable	3.3M	2.6M	3.2M	5.2M	6.0M	3.1M
Cash	32.1M	436.2M	202.0M	150.3M	172.8M	181.5M
Short Term Investments	133.0M	109.8M	422.4M	592.0M	680.8M	714.9M
Other Current Assets	38.6M	233.4M	85.6M	19.0M	21.8M	21.4M
Common Stock	110K	123K	128K	130K	149.5K	83.9K
Property Plant Equipment	32.0M	30.6M	61.0M	37.6M	43.2M	45.4M
Property Plant And Equipment Net	57.2M	61.0M	63.3M	61.6M	70.8M	74.4M
Net Debt	185.8M	(178.8M)	56.0M	106.6M	122.6M	128.8M
Non Current Assets Total	124.5M	432.0M	302.0M	138.0M	158.7M	166.6M
Non Currrent Assets Other	65.1M	368.9M	236.7M	74.3M	85.5M	46.8M
Cash And Short Term Investments	165.0M	546.0M	624.4M	742.3M	853.6M	896.3M
Common Stock Total Equity	84K	110K	123K	128K	147.2K	85.0K
Non Current Liabilities Total	217.2M	260.5M	254.8M	312.8M	359.8M	377.7M
Property Plant And Equipment Gross	57.2M	61.0M	63.3M	93.4M	107.4M	112.8M
Total Current Assets	228.7M	607.3M	683.8M	859.1M	988.0M	1.0B
Accumulated Other Comprehensive Income	273K	(2.3M)	(5.4M)	(2.1M)	(1.9M)	(2.0M)
Net Receivables	22.7M	131.8M	147.5M	44.5M	51.2M	53.8M
Other Liab	1.3M	2.6M	5.7M	384K	345.6K	328.3K
Good Will	2.3M	2.1M	2.0M	2.1M	1.9M	1.8M
Inventory	63.7M	61.3M	59.4M	53.3M	61.3M	64.3M
Short Long Term Debt Total	217.8M	257.4M	258.0M	256.9M	295.5M	148.9M
Long Term Debt	179.8M	220.5M	221.6M	222.7M	256.1M	268.9M
Short Term Debt	3.2M	2.6M	3.6M	4.5M	4.0M	4.6M
Net Tangible Assets	3.7M	56.4M	220.2M	579.0M	665.9M	699.2M
Retained Earnings Total Equity	(1.2B)	(1.3B)	(1.2B)	(924.2M)	(831.8M)	(873.4M)
Capital Surpluse	1.2B	1.4B	1.4B	1.5B	1.7B	1.1B
Non Current Liabilities Other	37.4M	5.7M	33.2M	74K	85.1K	80.8K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

Additional Tools for Dynavax Stock Analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Dynavax Long Term Debt vs Deferred Long Term Liab Analysis

Long Term Debt vs Deferred Long Term Liab

Long Term Debt vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Long Term Debt

Deferred Long Term Liab

Dynavax Technologies fundamental ratios Correlations

Dynavax Technologies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Dynavax Technologies fundamental ratios Accounts

Also Currently Popular

Additional Tools for Dynavax Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock Total Equity	+ 1.0	Common Stock
Total Current Assets	+ 1.0	Cash And Short Term Investments
Non Currrent Assets Other	+ 0.99	Other Current Liab
Cash And Short Term Investments	+ 0.98	Total Assets
Total Current Assets	+ 0.98	Total Assets
Property Plant And Equipment Net	+ 0.98	Common Stock Shares Outstanding

Other Stockholder Equity	- 0.78	Retained Earnings
Property Plant Equipment	- 0.73	Retained Earnings
Common Stock Shares Outstanding	- 0.67	Retained Earnings
Accounts Payable	- 0.65	Retained Earnings
Property Plant And Equipment Net	- 0.64	Retained Earnings
Total Liab	- 0.61	Retained Earnings